Research & Literature

Impact of Disease Duration on Vascular Surrogates of Early Atherosclerosis in Childhood-Onset Systemic Lupus Erythematosus.

Barsalou J, Bradley TJ, Tyrrell PN, et al.

Arthritis & rheumatology (Hoboken, N.J.) 2016; (68(1)):237-46 doi:10.1002/art.39423.

Risk Factors for Symptomatic Avascular Necrosis in Childhood-onset Systemic Lupus Erythematosus.

Yang Y, Kumar S, Lim LS, et al.

The Journal of rheumatology 2015; (42(12)):2304-9 doi:10.3899/jrheum.150464.

The association between initial manifestations of childhood-onset systemic lupus erythematosus and the survival.

Fatemi A, Matinfar M, Saber M, Smiley A

International journal of rheumatic diseases 2016; (19(10)):974-980 doi:10.1111/1756-185X.12807.

Belimumab for the treatment of corticosteroid-dependent systemic lupus erythematosus: from clinical trials to real-life experience after 1 year of use in 48 Brazilian patients.

Scheinberg M, de Melo FF, Bueno AN, et al.

Clinical rheumatology 2016; (35(7)):1719-23 doi:10.1007/s10067-016-3268-z.

Comparison of ethnicity, gender, age of onset and outcome in South Africans with systemic lupus erythematosus.

Budhoo A, Mody GM, Dubula T, et al.

Lupus 2017; (26(4)):438-446 doi:10.1177/0961203316676380.

Age of onset influences on clinical and laboratory profile of patients with systemic lupus erythematosus.

Sassi RH, Hendler JV, Piccoli GF, et al.

Clinical rheumatology 2017; (36(1)):89-95 doi:10.1007/s10067-016-3478-4.

Treatable renal disease in children with silent lupus nephritis detected by baseline biopsy: association with serum C3 levels.

Wakiguchi H, Takei S, Kubota T, et al.

Clinical rheumatology 2017; (36(2)):433-437 doi:10.1007/s10067-016-3491-7.

Evaluation of quality indicators and disease damage in childhood-onset systemic lupus erythematosus patients.

Harris JG, Maletta KI, Kuhn EM, Olson JC

Clinical rheumatology 2017; (36(2)):351-359 doi:10.1007/s10067-016-3518-0.

Magnetic resonance imaging in neuropsychiatric systemic lupus erythematosus: current state of the art and novel approaches.

Postal M, Lapa AT, Reis F, et al.

Lupus 2017; (26(5)):517-521 doi:10.1177/0961203317691373.

Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China.

Liu AC, Yang Y, Li MT, et al.

Clinical rheumatology 2018; (37(1)):93-100 doi:10.1007/s10067-017-3625-6.

Fatigue and depression predict reduced health-related quality of life in childhood-onset lupus.

Donnelly C, Cunningham N, Jones JT, et al.

Lupus 2018; (27(1)):124-133 doi:10.1177/0961203317716317.

Systemic lupus erythematosus, following prodromal idiopathic thrombocytopenic purpura, presenting with skin lesions resembling malignant atrophic papulosis.

Wallace MP, Thomas JM, Meligonis G, Ha T

Clinical and experimental dermatology 2017; (42(7)):774-776 doi:10.1111/ced.13158.

Measuring Disease Damage and Its Severity in Childhood-Onset Systemic Lupus Erythematosus.

Holland MJ, Beresford MW, Feldman BM, et al.

Arthritis care & research 2018; (70(11)):1621-1629 doi:10.1002/acr.23531.

Characteristics of 1555 childhood-onset lupus in three groups based on distinct time intervals to disease diagnosis: a Brazilian multicenter study.

Novak GV, Molinari BC, Ferreira JC, et al.

Lupus 2018; (27(10)):1712-1717 doi:10.1177/0961203318787037.

B Cells as a Therapeutic Target in Paediatric Rheumatic Disease.

Wilkinson MGL, Rosser EC

Frontiers in immunology 2019; (10()):214 doi:10.3389/fimmu.2019.00214.

Non-pharmacologic therapies for systemic lupus erythematosus.

Fangtham M, Kasturi S, Bannuru RR, et al.

Lupus 2019; (28(6)):703-712 doi:10.1177/0961203319841435.

Comparison among ACR1997, SLICC and the new EULAR/ACR classification criteria in childhood-onset systemic lupus erythematosus.

Rodrigues Fonseca A, Felix Rodrigues MC, Sztajnbok FR, et al.

Advances in rheumatology (London, England) 2019; (59(1)):20 doi:10.1186/s42358-019-0062-z.

Depressive and anxiety symptom prevalence in childhood-onset systemic lupus erythematosus: A systematic review.

Quilter MC, Hiraki LT, Korczak DJ

Lupus 2019; (28(7)):878-887 doi:10.1177/0961203319853621.

Aquaporin-4 IgG antibody-related disorders in patients with juvenile systemic lupus erythematosus.

Moraitis E, Stathopoulos Y, Hong Y, et al.

Lupus 2019; (28(10)):1243-1249 doi:10.1177/0961203319855125.

Cerebral blood flow abnormalities in neuropsychiatric systemic lupus erythematosus.

Jia J, Xie J, Li H, et al.

Lupus 2019; (28(9)):1128-1133 doi:10.1177/0961203319861677.

Quality of Care in Childhood-onset Systemic Lupus Erythematosus: Report of an Intervention to Improve Cardiovascular and Bone Health Screening.

Smitherman EA, Huang B, Furnier A, et al.

The Journal of rheumatology 2020; (47(10)):1506-1513 doi:10.3899/jrheum.190295.

Biomarkers associating endothelial Dysregulation in pediatric-onset systemic lupus erythematous.

Lee WF, Wu CY, Yang HY, et al.

Pediatric rheumatology online journal 2019; (17(1)):69 doi:10.1186/s12969-019-0369-7.

Neuromyelitis optica spectrum disorder and systemic lupus erythematosus.

Thabah MM, D S, Pranov R, et al.

Lupus 2019; (28(14)):1722-1726 doi:10.1177/0961203319888692.

EULAR/ACR classification criteria for SLE.

Aringer M

Seminars in arthritis and rheumatism 2019; (49(3S)):S14-S17 doi:10.1016/j.semarthrit.2019.09.009.

Exclusion of Cutaneous Lupus Erythematosus Subtypes From the 2019 European League Against Rheumatism/American College of Rheumatology Classifi cation Criteria for Systemic Lupus Erythematosus: Comment on the Article by Aringer et al.

Zapata L, Chong BF

Arthritis & rheumatology (Hoboken, N.J.) 2020; (72(8)):1403 doi:10.1002/art.41296.

Clinical features, disease activity and outcomes of Malaysian children with paediatric systemic lupus erythematosus: A cohort from a tertiary centre.

Lim SC, Chan EWL, Tang SP

Lupus 2020; (29(9)):1106-1114 doi:10.1177/0961203320939185.

Childhood-Onset Systemic Lupus Erythematosus: Southeast Asian Perspectives.

Tang SP, Lim SC, Arkachaisri T

Journal of clinical medicine 2021; (10(4)) doi:10.3390/jcm10040559.

Patient-Reported Outcomes for Quality of Life in SLE: Essential in Clinical Trials and Ready for Routine Care.

Nguyen MH, Huang FF, O'Neill SG

Journal of clinical medicine 2021; (10(16)) doi:10.3390/jcm10163754.

Trends in actual medication use for child-onset systemic lupus erythematosus using the Japanese health insurance database 2009-18.

Kishi T, Sakai R, Tani Y, et al.

Modern rheumatology 2022; (32(3)):565-570 doi:10.1093/mr/roab038.

Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 20 Moroccan adult patients.

Wafa A, Hicham H, Naoufal R, et al.

Clinical rheumatology 2022; (41(7)):2021-2033 doi:10.1007/s10067-022-06055-9.

Comparison of clinical presentation and outcome of childhood-onset and adulthood-onset of systemic lupus erythematosus among Indonesian patients.

Hamijoyo L, Sapartini G, Rahmadi AR, et al.

Lupus 2022; (31(6)):759-764 doi:10.1177/09612033221093482.

Non-pharmacologic therapies in treatment of childhood-onset systemic lupus erythematosus: A systematic review.

Ross E, Abulaban K, Kessler E, Cunningham N

Lupus 2022; (31(7)):864-879 doi:10.1177/09612033221094704.

A Rare Case of Systemic Lupus Erythematosus Manifesting as Genital Ulcers.

Paidi G, V H

Cureus 2022; (14(4)):e23818 doi:10.7759/cureus.23818.

Evans Syndrome in the Context of Incomplete Systemic Lupus Erythematosus.

Abu Kar S, Kaur A

Cureus 2022; (14(6)):e25795 doi:10.7759/cureus.25795.

Neuropsychiatric manifestations in childhood-onset systemic lupus erythematosus.

Appenzeller S, Pereira DR, Julio PR, et al.

The Lancet. Child & adolescent health 2022; (6(8)):571-581 doi:10.1016/S2352-4642(22)00157-2.

Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force.

Smith EMD, Aggarwal A, Ainsworth J, et al.

Annals of the rheumatic diseases 2023; (82(6)):788-798 doi:10.1136/ard-2022-223328.

Clinical characteristics of early-onset paediatric systemic lupus erythematosus in a single centre in China.

Hou Y, Wang L, Luo C, et al.

Rheumatology (Oxford, England) 2023; (62(10)):3373-3381 doi:10.1093/rheumatology/kead086.

Ischemic Vaso-occlusive Retinopathy as Initial Presentation in Pediatric Systemic Lupus Erythematosus: A Case Report.

Jeon JH, Choi HY, Rhim JW, et al.

Journal of rheumatic diseases 2022; (29(1)):52-55 doi:10.4078/jrd.2022.29.1.52.

Psychiatric manifestations of systemic lupus erythematosus: A brief review with two case-reports.

Kassim FM, Wordefo DK, Berhanu M, et al.

SAGE open medical case reports 2024; (12()):2050313X241229010 doi:10.1177/2050313X241229010.

Juvenile neuropsychiatric systemic lupus erythematosus: A specific clinical phenotype and proposal of a probability score.

Labouret M, Trebossen V, Ntorkou A, et al.

Lupus 2024; (33(4)):328-339 doi:10.1177/09612033241229022.

Using Diagnostic Radiological Imaging Modalities to Explore Neurological Dysfunction and Renal Failure in the Intersection of Hemophagocytic Lymphohistiocytosis, Macrophage Activation Syndrome, and Lupus.

Cazzaniga J, Georgiyeva K, Siguenza A, et al.

Cureus 2024; (16(2)):e54005 doi:10.7759/cureus.54005.

Diagnosis and Management of Pediatric Neuropsychiatric Systemic Lupus Erythematosus: An Update.

Unal D, Cam V, Emreol HE, Özen S

Paediatric drugs 2024; (26(4)):381-395 doi:10.1007/s40272-024-00632-y.

Genetic variants in UNC93B1 predispose to childhood-onset systemic lupus erythematosus.

Al-Azab M, Idiiatullina E, Liu Z, et al.

Nature immunology 2024; (25(6)):969-980 doi:10.1038/s41590-024-01846-5.

Gain-of-function human UNC93B1 variants cause systemic lupus erythematosus and chilblain lupus.

David C, Arango-Franco CA, Badonyi M, et al.

The Journal of experimental medicine 2024; (221(8)) doi:10.1084/jem.20232066.

UNCovering new causes of monogenic systemic lupus erythematosus.

Ellyard JI, Gantier MP

Immunology and cell biology 2024; (102(8)):651-654 doi:10.1111/imcb.12807.

Macrophage activation syndrome as a presenting feature in juvenile systemic lupus erythematosus.

Ramadoss I, Rengabashyam P, Seetharaman Varadhan M, Ponniah Subramanian AR

Lupus 2024; (33(11)):1254-1259 doi:10.1177/09612033241272972.

Case Report: p40 deficiency underlying pediatric-onset systemic lupus erythematosus.

Nieto-Patlán A, Fernández Dávila NS, Wang Y, et al.

Frontiers in pediatrics 2024; (12()):1425874 doi:10.3389/fped.2024.1425874.

Evaluating anchor variables and variation in meaningful score differences for PROMIS® Pediatric measures in children and adolescents living with a rheumatic disease.

Zigler CK, Li Z, Hernandez A, et al.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2024; (33(12)):3449-3457 doi:10.1007/s11136-024-03800-2.

Immune-mediating and immunosuppressive pharmacotherapies for proliferative lupus nephritis.

Moroni G, Reggiani F, Ponticelli C

Expert opinion on pharmacotherapy 2024; (25(15)):2061-2076 doi:10.1080/14656566.2024.2416038.

Insights into pediatric lupus nephritis: clinical features and short-term outcomes from a single center retrospective study.

Khatri S, Bajeer IA, Aziz M, et al.

BMC nephrology 2025; (26(1)):145 doi:10.1186/s12882-025-04059-6.

Early Atherosclerosis in Pediatric Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis.

Patra PK, Banday AZ, Asghar A, et al.

International journal of rheumatic diseases 2025; (28(4)):e70217 doi:10.1111/1756-185X.70217.

A Cytokine Storm Unveiled: Diagnostic Challenges of Macrophage Activation Syndrome in the Context of Undiagnosed Systemic Lupus Erythematosus in an Adolescent.

Devadkar AP, Kanitkar SA

Annals of African medicine 2026; (25(2)):467-470 doi:10.4103/aam.aam_99_25.

Evaluating the Applicability of the EULAR/ACR 2019, SLICC 2012, and ACR 1997 Classification Criteria for Systemic Lupus Erythematosus in Children: A Multicenter Study.

Qiao J, Ma Y, Zhang X, et al.

The Journal of rheumatology 2026; (53(6)):679-685 doi:10.3899/jrheum.2025-0559.

DNA Methylation Profiling Reveals Distinct Epigenetic Clusters and Suggests Epigenetic Patterns Associated With Sex and Disease Activity in Childhood-Onset Lupus.

Casares-Marfil D, Kavrul Kayaalp G, Guliyeva V, et al.

Arthritis & rheumatology (Hoboken, N.J.) 2026; (78(6)):1245-1257 doi:10.1002/art.70045.

Long-term outcomes of patients with moderate-severe pediatric systemic lupus erythematosus treated with combination rituximab and cyclophosphamide therapy: A single center cohort experience and review of literature.

Achar A, Houser P, Cherian J, Nuruzzaman F

Lupus 2026; (35(8)):842-850 doi:10.1177/09612033261441392.

The effect of belimumab combined with conventional treatment on NK cell count in childhood systemic lupus erythematosus.

Han H, Feng Q, Song X, Min Y

BMC rheumatology 2026; (10(1)).

Genetic landscape of early-onset systemic lupus erythematous in India.

Sharma M, Pilania RK, Volpi S, et al.

Rheumatology (Oxford, England) 2026; (65(6)) doi:10.1093/rheumatology/keaf631.